Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 52.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 125,299 shares of the medical equipment provider's stock after selling 138,734 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Intuitive Surgical were worth $62,057,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Atala Financial Inc acquired a new stake in Intuitive Surgical in the 4th quarter valued at $25,000. Parvin Asset Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $26,000. Global Financial Private Client LLC grew its stake in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the period. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the 4th quarter valued at $28,000. Finally, Hurley Capital LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ISRG. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada cut their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Evercore ISI decreased their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president now owns 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,998 shares of company stock worth $2,611,577. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $509.49 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00. The firm has a 50 day moving average price of $527.71 and a 200 day moving average price of $537.69. The company has a market capitalization of $182.61 billion, a PE ratio of 74.71, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the firm earned $1.50 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.